Dr Lew Lim, PhD, MBA, DNM, FCMA, CA(M), Grad Cert (Eng) is a Doctor of Natural Medicine, with graduate degrees, diplomas, certifications and professional credentials in engineering, neuroscience, business and accountancy. He obtained these from the University of California, Berkeley, Sheffield University, Duke University, Quantum University, Chartered Institute of Management Accountants (UK) and others.

He is widely recognized as an expert on photobiomodulation (PBM), particularly in its application for brain functions and the effect on the immune system. He owns the largest number of worldwide issued and pending patents related to PBM as an individual.

Nazanin has a MSc in Physics and a PhD in Medical Biophysics from University of Toronto, located at Sunnybrook Hospital.

Naz leads our covid-19 pivotal clinical trial and manages research projects in collaboration with the University of Alberta and Baycrest Hospital.

Given her background in biophysics, Naz’s passion aligns with Vielight’s goal of discovering how light energy could be used optimally to positively impact human physiology.

Genane holds a MSc in Neuroscience from McMaster University and a PhD in Pharmacology from the University of Toronto.

Gena manages Vielight’s research projects with various organizations for cognitive science, such as combining photobiomodulation with EEG.

Gena is passionate about neuroscience and a strong believer in the potential of photobiomodulation for improving mental acuity and brain health.

Mahroo has a MSc in Tissue Engineering and Biomaterial Sciences and a PhD in Pharmaceutical and Biomaterial Science from University College London in the UK.

Mahroo is investigating the potential beneficial effects of photobiomodulation in elderly cognition and brain aging. She also researches the effects of photobiomodulation on neuro-oscillations.

Her interest in tissue engineering has lead her to find ways on how light energy could affect cellular mechanisms.

Zara is a medical doctor. She has a post-doctorate from the Psychiatry Department at Isfahan University of Medical science in collaboration with Freiburg University of Medical Science, Psychiatry department.

Dr. Abbaspour is involved in the research of the interactions of neurons with NIR energy and the corresponding effects on memory and mental acuity.

As a doctor, she is interested in the potential of photobiomodulation to address neurodegenerative diseases.

Janine holds a PhD in Biochemistry from Queens University, Ontario. Janine has been a part of Vielight since its founding.

Presently, she manages and handles Vielight’s pivotal Alzheimer’s disease clinical trial – including protocol planning, recruitment and operations.

Janine utilizes her decade-long experience in the field of photobiomodulation to help further discoveries.

Dr. Elisabeth Wilde is an Associate Professor in the Department of Neurology at the University of Utah. She also holds an appointment as a Health Research Scientist at the VA Salt Lake City Healthcare System.

She was a primary researcher in a groundbreaking n=49 TBI study, conducted at the University of Utah with ex-footballers, using the Vielight Neuro Gamma. The study is pending publication.

Dr. Tuszynski is a Fellow of the National Institute for Nanotechnology of Canada. He is an Allard Chair and Professor in Experimental Oncology in the Department of Oncology at the University of Alberta’s Cross Cancer Institute and a Professor in the Department of Physics.

His research conducted with the Vielight Neuro Alpha provides a deeper level of understanding of the way living cells, cellular structures, and components such as microtubules respond to NIR photobiomodulation.

Dr. Margaret Naeser is Research Professor of Neurology, Boston University School of Medicine and Research Linguist/Speech-Language Pathologist, V.A. Boston Healthcare System.

Dr. Naeser has published multiple TBI and CTE studies using Vielight Neuro technology on US Army Veterans.

Dr. Reza Zomorrodi has a PhD in Nuclear Physics and a PhD in Computational Neuroscience from Université Laval in Quebec.

Dr. Zomorrodi was the first in the world to publish a scientific paper showing the neuromodulatory effects of NIR light energy on the brain. The study used the Vielight Neuro Gamma. To date, the Vielight Neuro Gamma is the only commercially available brain photobiomodulation device to demonstrate neuromodulatory effects in a peer-reviewed published study in a high level journal.

Linda Chao, PhD, is a Professor in the Department of Radiology and Biomedical Imaging and in the Department of Psychiatry at the University of California, San Francisco. Dr. Chao obtained her BS in Biological Science from the University of California, Davis in 1991, and she completed her PhD studies in Neuroscience from UCD in 1996. For the past 11-years, she has served as leader for the Psychiatry Block.

Dr. Chao was the first to successfully combine fMRI imaging with brain photobiomodulation research to evidence neurophysiological changes in Alzheimer’s patients. She used the Vielight Neuro in her studies.

Dr. David Tate is a clinical neuropsychologist trained at Brigham Young University and Brown Medical School. He is heavily involved in medical imaging research used to examine a number of developmental, clinical, and medical disorders including traumatic brain injury.

Dr. Tate was a primary researcher in a groundbreaking n=49 TBI study, conducted at the University of Utah with ex-footballers, using the Vielight Neuro Gamma. The study is pending publication.

Dr. Neda Rashidi-Ranjbar a Clinician Scientist holding both an MD and a PhD, currently serves as a postdoctoral fellow at St. Michael’s Hospital. She earned her doctoral degree in medical science from the University of Toronto. At present, Dr. Nana is at the forefront of pioneering research focused on the application of photobiomodulation (PBM) for the treatment of Mild Cognitive Impairment (MCI).

Dr. Larry Carr is a former BYU graduate and BYU Hall of Fame Football player. He received a Ph.D. from BYU in exercise physiology and taught at the university level until CTE-like symptoms forced him to step down.

Dr. Carr was enrolled in a CTE-study by Dr. Naeser and was inspired by the Vielight Neuro’s ability to greatly improve his CTE-symptoms, bringing him back to baseline. As such, he now leads several research initiatives for brain photobiomodulation, TBI and CTE at the U of Utah.

Dr. Chen received her MSc (2004) in Electrical Engineering from the University of Calgary, and her PhD (2009) in Biomedical Engineering from McGill University. She completed her postdoctoral work on multimodal MRI of brain aging at Harvard Medical School (2011). She is a Senior Scientist at the Rotman Research Institute and Tier II Canada Research Chair in Neuroimaging of Aging.

Dr. Chen is conducting fMRI-based studies with Vielight technology on the brain, to help discover optimal brain photobiomodulation parameters.

Prof M.R. Hamblin (Ph.D.) was the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology.

Dr. Hamblin co-authored the world’s first published study suggesting efficacy for brain photobiomodulation for Alzheimer’s Disease. The study featured Vielight Neuro technology.

Dr. Javier Peña currently works at the Faculty of Psychology and Education, University of Deusto. Javier does research in Neuropsychology, Abnormal Psychology, Clinical Psychology and creativity. Their current project is ‘Neurocrea Project’.

Dr. Peña co-authored the first published study linking brain photobiomodulation to improved creativity. The study featured Vielight Neuro technology.